ArticleBriefings in bioinformatics2026
A two-stage GAN-based instrumental variable method for causal analysis of omics data.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
While considerable progress has been made in identifying candidate genes associated with complex diseases, their potential causal roles in disease etiology remain unknown. Mendelian randomization (MR) utilizes genetic variants as instrumental variables (IVs) to estimate the causal effects of disease-associated genes, thereby establishing putative causal associations and reducing spurious association findings due to confounding. To mitigate the potential bias due to the violation of IV conditions and nonlinear exposure-outcome relations in MR studies, we propose a two-stage deep learning framework, which is free from distribution assumptions of exposure given IVs and flexible to capture complex exposure-outcome relations. Specifically, we adapt the generative adversarial networks (GAN) to estimate the conditional distribution of gene expression given IVs in the first stage and apply deep functional neural networks to learn the causal relationships between gene expression and outcomes. Moreover, the proposed method is flexible to handle various data types, such as multiple gene expressions and multi-omics data. Through simulation studies under different distributions and model choices, our proposed GAN-based instrumental variable (GAN-IV) method demonstrates improved performance over the two-stage least squares method, pleiotropy-robust MR methods (e.g. MR-LINK), and state-of-the-art deep-learning-based methods (e.g. DeLIVR). A real data application on the ROSMAP dataset further illustrates that GAN-IV is capable of capturing the exposure distribution and complex nonlinear causal effect between gene expression and disease phenotype. Overall, the proposed GAN-IV framework provides a powerful and distribution-free tool for complex omics data, and accounts for unobserved pleiotropy and linkage disequilibrium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.